-Reuters Interview
What’s Going On With Beam Therapeutics Stock Thursday?
Beam Therapeutics Inc (NASDAQ: BEAM) shares are trading lower Thursday.
GE CEO Culp Says Supply Chain Continues To Be A Challenge
-Reuters Interview
Related Posts
Bitcoin, Ethereum, Dogecoin Drop Amid $116M Liquidations: Analyst Says King Crypto To Surge Over 30% In Two Days After This Catalyst Is Triggered
The cryptocurrency market experienced a minor downturn on Tuesday, resulting in the liquidation of 51,441 future crypto traders and a total liquidation value of $116.07 million within the past 24 hours.
Morgan Stanley Analyst’s Car Shopping Experience Showed Him How Similar Tesla Is To Amazon Prime
Morgan Stanley analyst Adam Jonas on Wednesday recounted his experience of buying a new vehicle and noted the advantages possessed by…
Gamida Cell Priced 12.9M Share Public Offering of Common Stock @$1.55/Share
Gamida Cell Ltd. (Nasdaq: GMDA) announced the pricing of a follow-on public offering of 12,905,000 of its ordinary shares at a public offering price of $1.55 per share for aggregate gross proceeds of $20 million, before deducting underwriting discounts and commissions and estimated offering expenses.